New York (AP) —Federal Judge on Friday ordered Martin Shkreli to return $ 64.6 million in profits from his and his company’s soaring prices for the life-saving drug Dalaprim, and his rest For a period of time, I banned participation in the pharmaceutical industry. life.
The decision by US District Judge Dennis Court came weeks after the seven-day bench trial in December. In 2020, the Federal Trade Commission and seven states filed a proceeding against a man dubbed “Pharmabro” in the media.
Sucreli was the CEO of the Turing Pharmaceuticals (later the VIERA TV) when the price of Dalaprim was soaring. Treats rare parasites that affect pregnant women, cancer patients, and AIDS patients.
He defended this decision as capitalism was working, and said insurance and other programs would ensure that those in need of Dalaprim would eventually get it.
However, the move has caused anger from the medical center on the trajectory of the 2016 presidential election, Hillary Clinton called it a price cut, and future President Donald Trump called Sukurelli a “spoiled kid.” is.
Suggest a fix
Sucreli was ordered to return $ 64 million and was locked out of the pharmaceutical industry | WGN Radio 720
Source link Sucreli was ordered to return $ 64 million and was locked out of the pharmaceutical industry | WGN Radio 720